Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases

Summary

Primary objectives: \- To determine the time to progression in subjects with breast cancer metastatic to bone only treated with 153Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation (PBSCT). Secondary objectives: * To determine the overall survival at one year. * To determine the efficacy of 153Sm-EDTMP at 6 months. * To assess pain in subjects treated with 153Sm-EDTMP. * To determine the safety of 153Sm-EDTMP.

Timeline

Start

2007-03

Primary completion

2014-11

Completion

2014-11

Drugs

Indications